New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)

10.06.2008 08:40:06
Boehringer Ingelheim: Ingelheim, Germany (ots/PRNewswire) - - First Ever Study to Demonstrate Efficacy of Pramipexole in Treating RLS-Associated Limb Pain - For Healthcare Media Outside the U.S.A. A new study demonstrating that pramipexole ...

Lesen Sie hier weiter... |  Drucken |  PDF

Ähnliche Artikel




stock-channel.net - Das Finanzportal - New Data Shows Pramipexole ...

New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)


New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly ...

New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS).Boehringer Ingelheim: Ingelheim,


GENIOS: Presse, Firmeninformationen, Jahresabschlüsse, Insolvenz ...

New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)


Bankkaufmann - News

New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)


Presseportal.de - Boehringer Ingelheim

New Data Shows Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Limb Pain in Patients With Restless Legs Syndrome (RLS)